The Manufacturers Life Insurance Company Buys New Stake in Merit Medical Systems, Inc. $MMSI

The Manufacturers Life Insurance Company purchased a new position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 484,435 shares of the medical instruments supplier’s stock, valued at approximately $33,591,000. The Manufacturers Life Insurance Company owned approximately 0.81% of Merit Medical Systems at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of MMSI. Kilter Group LLC purchased a new position in shares of Merit Medical Systems during the second quarter worth about $25,000. Los Angeles Capital Management LLC acquired a new stake in shares of Merit Medical Systems during the fourth quarter worth about $25,000. Torren Management LLC purchased a new stake in shares of Merit Medical Systems in the 4th quarter valued at about $38,000. Covestor Ltd lifted its holdings in shares of Merit Medical Systems by 252.6% in the 4th quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock valued at $41,000 after purchasing an additional 336 shares during the last quarter. Finally, Danske Bank A S acquired a new stake in shares of Merit Medical Systems in the 3rd quarter valued at about $42,000. 99.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on MMSI shares. Raymond James Financial reaffirmed an “outperform” rating and set a $100.00 price target on shares of Merit Medical Systems in a research report on Friday, July 31st. JPMorgan Chase & Co. increased their price objective on Merit Medical Systems from $77.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, July 31st. Canaccord Genuity Group raised their target price on shares of Merit Medical Systems from $85.00 to $94.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Weiss Ratings raised shares of Merit Medical Systems from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, August 18th. Finally, Wells Fargo & Company increased their price target on shares of Merit Medical Systems from $74.00 to $83.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Eight research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Merit Medical Systems presently has a consensus rating of “Moderate Buy” and an average target price of $100.00.

Merit Medical Systems Stock Down 0.6%

MMSI opened at $90.54 on Thursday. Merit Medical Systems, Inc. has a 52 week low of $59.74 and a 52 week high of $94.75. The business has a 50 day moving average price of $78.85 and a two-hundred day moving average price of $72.74. The company has a quick ratio of 2.79, a current ratio of 4.20 and a debt-to-equity ratio of 0.44. The company has a market cap of $5.41 billion, a PE ratio of 37.41, a P/E/G ratio of 2.27 and a beta of 0.49.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.23. The company had revenue of $418.84 million for the quarter, compared to the consensus estimate of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The company’s revenue was up 9.5% on a year-over-year basis. During the same period last year, the business posted $1.01 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, research analysts anticipate that Merit Medical Systems, Inc. will post 3.84 EPS for the current year.

More Merit Medical Systems News

Here are the key news stories impacting Merit Medical Systems this week:

• Positive Sentiment: Zacks Research raised several earnings forecasts. The firm increased its FY2026 EPS estimate to $3.73 from $3.57, FY2027 to $4.01 from $3.82, and FY2028 to $4.32 from $4.12. It also lifted estimates for Q2 2027, Q3 2027, Q1 2028, and Q2 2028. The revisions suggest improved confidence in Merit Medical’s longer-term earnings growth.
• Positive Sentiment: Longer-term earnings expectations are moving higher. The revised FY2027 and FY2028 forecasts exceed the current-year consensus estimate of roughly $3.81–$3.84 per share, reinforcing the outlook for continued earnings expansion.
• Neutral Sentiment: Short-interest data appears unusable. The report lists short interest at zero shares and describes the change as “NaN,” with a zero days-to-cover ratio. This does not provide a meaningful signal about short-selling pressure or potential short covering.
• Negative Sentiment: One near-term estimate was reduced. Zacks lowered its Q4 2026 EPS forecast slightly to $0.98 from $0.99. While the change is minor, it offsets some of the broader positive revisions and indicates limited near-term earnings impact.
• Negative Sentiment: Valuation leaves less room for disappointment. Merit Medical’s shares recently traded near their 52-week high, with a P/E ratio above 37 and a PEG ratio above 2. Stronger earnings expectations are supportive, but the premium valuation could weigh on the stock if results or guidance fall short.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.